Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q9CI
|
|||
Former ID |
DNC006159
|
|||
Drug Name |
N-methoxyethyl estrone-16-methyl carboxamide
|
|||
Synonyms |
SCHEMBL12379530
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C23H31NO4
|
|||
Canonical SMILES |
CC12CCC3C(C1CC(C2=O)CC(=O)NCCOC)CCC4=C3C=CC(=C4)O
|
|||
InChI |
1S/C23H31NO4/c1-23-8-7-18-17-6-4-16(25)11-14(17)3-5-19(18)20(23)12-15(22(23)27)13-21(26)24-9-10-28-2/h4,6,11,15,18-20,25H,3,5,7-10,12-13H2,1-2H3,(H,24,26)/t15?,18?,19?,20?,23-/m0/s1
|
|||
InChIKey |
LQHCZQAKWAQLJZ-OOGUNDJRSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) | Target Info | Inhibitor | [1] |
BioCyc | Superpathway of steroid hormone biosynthesis | |||
Estradiol biosynthesis I | ||||
KEGG Pathway | Steroid hormone biosynthesis | |||
Metabolic pathways | ||||
Ovarian steroidogenesis | ||||
NetPath Pathway | FSH Signaling Pathway | |||
Panther Pathway | Androgen/estrogene/progesterone biosynthesis | |||
Pathwhiz Pathway | Androgen and Estrogen Metabolism | |||
Reactome | The canonical retinoid cycle in rods (twilight vision) | |||
WikiPathways | Steroid Biosynthesis | |||
Metabolism of steroid hormones and vitamin D | ||||
Prostate Cancer |
References | Top | |||
---|---|---|---|---|
REF 1 | Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. J Med Chem. 2006 Feb 23;49(4):1325-45. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.